WILSONVILLE, Ore., February 9, 2016 /PRNewswire-iReach/
For Immediate Release
RevMedx™ Announces Addition of XSTAT® to the Tactical Combat Casualty Care Guidelines.
RevMedx, Inc. today announced that the Committee on Tactical Combat Casualty Care (CoTCCC) has added XSTAT to the Tactical Combat Casualty Care (TCCC) guidelines as a treatment for hemorrhage not amenable to limb tourniquet use.
XSTAT is a first-in-kind hemostatic device for the treatment of severe bleeding in the axilla or groin area (known as junctional wounds). XSTAT works by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator. In a wound, the sponges expand and swell to fill the wound cavity within 20 seconds of contact with blood. This process creates a temporary barrier to blood flow and provides hemostatic pressure. Each sponge contains an x-ray detectable marker to aid in surgical removal.
“We are pleased to have XSTAT added to the TCCC guidelines. The achievement of this milestone is a strong validation of our innovative approach to treating gunshot wounds and other penetrating injuries,” said Andrew Barofsky, president and CEO of RevMedx. “This significant development reflects RevMedx’s commitment to providing life-saving devices for first responders around the world.”
Early control of severe bleeding may prevent shock and may be life-saving. The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility.
CoTCCC is a subgroup of the Trauma and Injury Subcommittee of the Defense Health Board which ensures that emerging technology and information is incorporated into current TCCC guidelines. Members of the CoTCCC represent all services and the civilian sector including medics, trauma surgeons, emergency medicine and critical care physicians, and medical researchers and educators. All services in the US military and many partner nations use TCCC to train combat medical personnel in the management of trauma on the battlefield.
Based in Wilsonville, Oregon, RevMedx is a privately held medical device company whose goal is to design, develop, and manufacture innovative medical products that save lives. Our product line includes XSTAT, XGAUZE, AIRWRAP, PARABELT, and TX Series Ratcheting Tourniquets. Additional information about RevMedx and our products can be found at www.revmedx.com.
VP Sales & Marketing
Phone: (503) 218-2172
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RevMedx, Inc.